Compendium of Organic Medicinal Drugs - Volume 1

'Compendium of Organic Medicinal Drugs (with detailed synthetic routes)' comprises six volumes of books which provide detailed information on the organic chemistry of top selling medical drugs. Volume 1 of this book series primarily deals with the Chemistry of Respiratory System and Gastrointestinal Drugs.Based on our knowledge, a chemistry review on the most common generic drugs presently available in the market has not been done before. Therefore, this book has emerged from the idea of providing comprehensive information on the available synthetic routes, physical properties, formulations, clinical pharmacology, toxicity data and applications for each medicinal drug compounds.In this volume, chemistries pertaining to Respiratory and Gastrointestinal drug compounds are described.Detailed synthetic routes with complete experimental details for the manufacture of drug compounds and their intermediates are provided with appropriate patent references. Disease based approach for classifying the generic drugs has been followed throughout the book.This volume will be more valuable to synthetic organic chemists, chemical producers and scientists engaged in the process and product development for the manufacture of active pharmaceutical ingredients (API) and medicinal drug compounds to know the details of drug's syntheses and their manufacturing procedures. We believe this volume would be a very good reference guide to all those involved in the pharmaceutical industry throughout the world. Contents Volume 1: Chemistry Of Respiratory System And Gastrointestinal Drugs1. Anti-Inflammatory And Antiallergy Drugs, 2. Anti-Tussive Drugs, 3. Anti-Asthma Drugs, 4. Antiemetic Drugs, 5. Anti-Irritable Bowel Syndrome (Ibs) Drugs, 6. Anti-Ulcer Drugs About the Authors Raj B. Durairaj, Ph.D., is currently working as a Technical Director for Techno WaxChem Pvt Ltd, Kolkata, India. Previously he worked as the Chief Technology Officer at Sino Legend Chemical, China for more than three and half years. In USA, he has worked as the Director of Research at Indspec Chemical Corporation (Manufacturer of Resorcinol and Resins) for 21 years. Dr. Durairaj obtained his Ph.D degree in Synthetic Organic Polymer Chemistry in 1981 from the University of Madras, India. He then moved to USA and worked as a researcher at Case Western Reserve University, Cleveland, Ohio (1981-1982), Drexel University, Philadelphia (1982-1985) and University of Connecticut, Storrs (1985-1986) before joining Koppers Company (Now Indspec Chemical Company) in 1986. For the past 30 years, Dr. Durairaj worked on various aspects of synthetic organic and polymer chemistry. Dr. Durairaj is the author of a book titled “Resorcinol: Chemistry, Technology and Application” published by Springer from Germany in 2005. He has published more than 42 technical papers and presentations published in international journals and proceedings. To his credit, he has published more than 122 international patents and publications. He is the inventor of several commercial (Penacolite® B-20-S) resorcinol based chemicals and resins. Magesh Sathaiah, MD, is currently working as a Research Associate at the Hillman Cancer Center, University of Pittsburgh Hillman Medical Center (UPMC), Pittsburgh, USA. Previously, he worked as a Research Fellow on a project “Biological Therapy in the Treatment of Cancer”, funded by National Institute of Health (NIH), USA for two years. Dr. Sathaiah graduated from the Dr. MGR Medical University, Chennai in 2005. His research is primarily focused on the novel biological therapies for cancer treatment, which include engineering oncolytic poxviruses for treating colon cancer. He has published more than 10 research papers in both gene therapy and clinical research.